πŸ‡ΊπŸ‡Έ FDA
Patent

US 6369063

Selective factor Xa inhibitors

expired A61KA61K38/00A61P

Quick answer

US patent 6369063 (Selective factor Xa inhibitors) held by COR Therapeutics, Inc. expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
COR Therapeutics, Inc.
Grant date
Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61P, A61P7/02, A61P9/00